Vertex to Announce Third Quarter 2024 Financial Results on November 4th
Vertex Pharmaceuticals (Nasdaq: VRTX) has announced that it will release its third quarter 2024 financial results on Monday, November 4, 2024, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results.
Interested parties can access the call by dialing (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and referencing the "Vertex Pharmaceuticals Third Quarter 2024 Earnings Call." A live webcast link will be available on Vertex's website in the "Investors" section. Participants are advised to register at least 15 minutes before the scheduled webcast to ensure a timely connection. An archived version of the webcast will be made available on the company's website for those unable to attend the live event.
Vertex Pharmaceuticals (Nasdaq: VRTX) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 lunedì 4 novembre 2024, dopo la chiusura dei mercati finanziari. L'azienda ospiterà una chiamata di conferenza e un webcast alle 16:30 ET per discutere i risultati.
Le parti interessate possono accedere alla chiamata componendo il numero (833) 630-2124 (USA) o +1 (412) 317-0651 (Internazionale) e facendo riferimento alla "Chiamata sugli utili del terzo trimestre 2024 di Vertex Pharmaceuticals." Un link per il webcast in diretta sarà disponibile sul sito web di Vertex nella sezione "Investitori". Si consiglia ai partecipanti di registrarsi almeno 15 minuti prima del webcast programmato per garantire una connessione tempestiva. Una versione archiviata del webcast sarà resa disponibile sul sito dell'azienda per coloro che non possono partecipare all'evento dal vivo.
Vertex Pharmaceuticals (Nasdaq: VRTX) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el lunes 4 de noviembre de 2024, después del cierre de los mercados financieros. La empresa organizará una llamada de conferencia y un webcast a las 4:30 p.m. ET para discutir los resultados.
Las partes interesadas pueden acceder a la llamada marcando (833) 630-2124 (EE. UU.) o +1 (412) 317-0651 (Internacional) y haciendo referencia a la "Llamada de ganancias del tercer trimestre 2024 de Vertex Pharmaceuticals." Un enlace de webcast en vivo estará disponible en la sección "Inversores" del sitio web de Vertex. Se aconseja a los participantes registrarse al menos 15 minutos antes del webcast programado para asegurar una conexión oportuna. Una versión archivada del webcast estará disponible en el sitio web de la compañía para aquellos que no puedan asistir al evento en vivo.
Vertex Pharmaceuticals (Nasdaq: VRTX)는 2024년 3분기 재무 결과를 2024년 11월 4일 월요일에 금융 시장이 종료된 후 발표할 것이라고 발표했습니다. 회사는 결과에 대해 논의할 컨퍼런스 콜과 웹캐스트를 오후 4시 30분 ET에 진행합니다.
관심 있는 분들은 (833) 630-2124 (미국) 또는 +1 (412) 317-0651 (국제)로 전화하여 "Vertex Pharmaceuticals 2024년 3분기 실적 전화"를 참조하여 접속할 수 있습니다. 웹사이트의 "투자자" 섹션에서 실시간 웹캐스트 링크를 이용할 수 있습니다. 참여자는 정시 연결을 보장하기 위해 예정된 웹캐스트 15분 전에 등록하는 것이 좋습니다. 실시간 이벤트에 참석할 수 없는 경우 회사 웹사이트에서 웹캐스트의 기록된 버전도 제공됩니다.
Vertex Pharmaceuticals (Nasdaq: VRTX) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 le lundi 4 novembre 2024, après la fermeture des marchés financiers. L’entreprise animera un appel de conférence et un webcast à 16h30 ET pour discuter des résultats.
Les parties intéressées peuvent accéder à l’appel en composant le (833) 630-2124 (États-Unis) ou le +1 (412) 317-0651 (International) et en faisant référence à "L'appel sur les résultats du troisième trimestre 2024 de Vertex Pharmaceuticals." Un lien vers le webcast en direct sera disponible sur le site web de Vertex dans la section "Investisseurs". Les participants sont conseillés de s'inscrire au moins 15 minutes avant le webcast prévu pour garantir une connexion rapide. Une version archivée du webcast sera disponible sur le site de l'entreprise pour ceux qui ne peuvent pas assister à l'événement en direct.
Vertex Pharmaceuticals (Nasdaq: VRTX) hat angekündigt, dass sie ihre Finanzergebnisse für das dritte Quartal 2024 am Montag, den 4. November 2024, nach Börsenschluss veröffentlichen wird. Das Unternehmen wird um 16:30 Uhr ET eine Konferenzschaltung und einen Webcast abhalten, um die Ergebnisse zu diskutieren.
Interessierte Parteien können an der Konferenz teilnehmen, indem sie (833) 630-2124 (USA) oder +1 (412) 317-0651 (International) anrufen und sich auf die "Vertex Pharmaceuticals Konferenz für die Finanzergebnisse des dritten Quartals 2024" beziehen. Ein Link zum Live-Webcast wird im Bereich "Investoren" auf der Website von Vertex verfügbar sein. Teilnehmer wird geraten, sich mindestens 15 Minuten vor dem geplanten Webcast anzumelden, um eine rechtzeitige Verbindung zu gewährleisten. Eine archivierte Version des Webcasts wird auf der Website des Unternehmens zur Verfügung stehen für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können.
- None.
- None.
The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.
Vertex was founded in 1989 and has its global headquarters in
(VRTX-WEB)
View source version on businesswire.com: https://www.businesswire.com/news/home/20241010368265/en/
Vertex Pharmaceuticals Incorporated Investor Relations:
investorinfo@vrtx.com
Source: Vertex Pharmaceuticals Incorporated
FAQ
When will Vertex Pharmaceuticals (VRTX) release its Q3 2024 financial results?
What time is Vertex Pharmaceuticals' (VRTX) Q3 2024 earnings call scheduled for?
How can investors access Vertex Pharmaceuticals' (VRTX) Q3 2024 earnings call?
Will there be a replay available for Vertex Pharmaceuticals' (VRTX) Q3 2024 earnings call?
